301617 Stock Overview
Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥48.20 |
| 52 Week High | CN¥55.48 |
| 52 Week Low | CN¥41.38 |
| Beta | 0 |
| 1 Month Change | 1.30% |
| 3 Month Change | -2.25% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 2.62% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301617 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 0.06% | -0.7% | 0.1% |
| 1Y | n/a | 0.6% | 9.4% |
Return vs Industry: Insufficient data to determine how 301617 performed against the CN Chemicals industry.
Return vs Market: Insufficient data to determine how 301617 performed against the CN Market.
Price Volatility
| 301617 volatility | |
|---|---|
| 301617 Average Weekly Movement | 6.3% |
| Chemicals Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 301617 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: Insufficient data to determine 301617's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 667 | Guoqing Yu | www.boyuanchemical.com |
Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sales of fine chemicals. The company offers iodine derivatives, such as potassium iodide, sodium iodide, potassium iodide, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldisilane, hexamethyldisiloxane, and tris[2-(2-methoxyethoxy)ethyl]amine.
Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. Fundamentals Summary
| 301617 fundamental statistics | |
|---|---|
| Market cap | CN¥4.95b |
| Earnings (TTM) | CN¥211.06m |
| Revenue (TTM) | CN¥1.34b |
Is 301617 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301617 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.34b |
| Cost of Revenue | CN¥1.01b |
| Gross Profit | CN¥331.54m |
| Other Expenses | CN¥120.49m |
| Earnings | CN¥211.06m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.05 |
| Gross Margin | 24.74% |
| Net Profit Margin | 15.75% |
| Debt/Equity Ratio | 0% |
How did 301617 perform over the long term?
See historical performance and comparisonDividends
Does 301617 pay a reliable dividends?
See 301617 dividend history and benchmarks| Shandong Boyuan Pharmaceutical & Chemical dividend dates | |
|---|---|
| Ex Dividend Date | May 26 2025 |
| Dividend Pay Date | May 26 2025 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 2 days |
Does 301617 pay a reliable dividends?
See 301617 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 21:47 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.